Women not routinely screened for pregnancy prior to chemoimmunotherapy, Aussie study reveals

Associate Professor Nada Hamad says assessing pregnancy status before treatment should be standard care.
Lauren Kelly
Associate Professor Nada Hamad.

Clinicians are calling for mandatory pregnancy tests for women undergoing chemotherapy in combination with immunotherapy.

It follows research from late last year which found only 17% of chemoimmunotherapy cycles screened patients for pregnancy before their treatment began.